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Background: Neural stem cell (NSC) differentiation is a complex multistep process that persists in specific regions
of the postnatal forebrain and requires tight regulation throughout life. The transcriptional control of NSC proliferation
and specification involves Class II (proneural) and Class V (Id1-4) basic helix-loop-helix (bHLH) proteins. In this study, we
analyzed the pattern of expression of their dimerization partners, Class I bHLH proteins (E-proteins), and explored their
putative role in orchestrating postnatal subventricular zone (SVZ) neurogenesis.
Results: Overexpression of a dominant-negative form of the E-protein E47 (dnE47) confirmed a crucial role for bHLH
transcriptional networks in postnatal neurogenesis by dramatically blocking SVZ NSC differentiation. In situ hybridization
was used in combination with RT-qPCR to measure and compare the level of expression of E-protein transcripts (E2-2,
E2A, and HEB) in the neonatal and adult SVZ as well as in magnetic affinity cell sorted progenitor cells and neuroblasts.
Our results evidence that E-protein transcripts, in particular E2-2 and E2A, are enriched in the postnatal SVZ with
expression levels increasing as cells engage towards neuronal differentiation. To investigate the role of E-proteins
in orchestrating lineage progression, both in vitro and in vivo gain-of-function and loss-of-function experiments
were performed for individual E-proteins. Overexpression of E2-2 and E2A promoted SVZ neurogenesis by enhancing
not only radial glial cell differentiation but also cell cycle exit of their progeny. Conversely, knock-down by shRNA
electroporation resulted in opposite effects. Manipulation of E-proteins and/or Ascl1 in SVZ NSC cultures indicated
that those effects were Ascl1 dependent, although they could not solely be attributed to an Ascl1-induced switch
from promoting cell proliferation to triggering cell cycle arrest and differentiation.
Conclusions: In contrast to former concepts, suggesting ubiquitous expression and subsidiary function for
E-proteins to foster postnatal neurogenesis, this work unveils E-proteins as being active players in the orchestration
of postnatal SVZ neurogenesis.
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Stem cell plasticityBackground
The self-renewal versus differentiation of neural stem
cells (NSCs) into new neurons is a highly complex process
and depends on tight regulatory mechanisms throughout
postnatal life. Early after birth, radial glia cells (RGCs)
mature into type-B cells that reside in the germinal niche
lining the lateral ventricles (LVs), namely the subventricular
zone (SVZ). These NSCs proliferate slowly (infrequently)* Correspondence: raineteau@hifo.uzh.ch
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unless otherwise stated.and by asymmetric division give rise to fast proliferating
cells, defined as type-C cells (or transit amplifying progeni-
tors). After 3 to 4 cycles of symmetric divisions, allowing
the pool of type-C cells to enlarge, these progenitors start
to differentiate and commit to specific fates [1]. At this
stage, they are defined as type-A cells (or neuroblasts),
which then migrate through the rostral migratory stream
(RMS) into the olfactory bulb [2,3] to terminally differ-
entiate into specific neuron subtypes (i.e., periglomerular
neurons and granule cells) [4].
To balance NSC maintenance and precursor differen-
tiation into neurons or glial cells, postnatal neurogenesis
relies on the timely integration of intracellular signaling
mechanisms such as the basic-helix-loop-helix (bHLH)Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
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a large family of transcription factors that are categorized
in several classes based on their structure and function [5]
and are believed to play an essential role in multiple
aspects of forebrain development. By virtue of their tran-
scriptional activity, bHLH proteins can be subdivided into
three groups, i.e., activators (Class II), repressors (Class
V), and transactivators (Class I) [6].
The classical view of bHLH protein interaction and
function is still largely based on drosophila studies [7-9]
and murine developmental studies [5,10-12]. There, bHLH
repressors (i.e., Hes and Id proteins) and activators (pro-
neural proteins, i.e., Ascl1, Neurog2) mutually antagonize
each other either by direct transcriptional repression
[13,14], physical inhibition [8,15], or by competing for
bHLH transactivators (E-proteins) [12,16]. This antagonis-
tic balance defines whether NSCs or their progeny are dif-
ferentiating or not, with bHLH repressors predominantly
favoring the retention of cells in immature stages [17,18],
while bHLH activators accelerate progenitor maturation
[13,14,19-22].
Recent work done in drosophila, however, indicates
that this established paradigm is likely to be over-simplified
and incomplete. A more sophisticated spatial and temporal
regulation of E-protein expression has been proposed,
suggesting that E-proteins (E2-2, E2A, HEB) fulfill a
more complex function than anticipated in germinal
zones of the central nervous system (CNS) [23,24]. Fur-
thermore, work in rodents implies that various E-proteins
exhibit differential patterns of expression at distinct ages,
resulting in the preferential formation of specific dimers
[25-27].
This complex pattern of expression, paired with a re-
cent study implicating Ascl1 in regulating both NSC pro-
liferation and differentiation [22], suggests that E-proteins
orchestrate NSC lineage progression, a hypothesis we
examine in the present study.
Results
Heterodimerization of Class I/II bHLH proteins is essential
for normal NSC differentiation in vitro and in vivo
NS5 cell cultures contain homogenous populations of
progenitors that divide indefinitely upon exposure to
FGF2 and EGF and undergo neuronal and glial differen-
tiation following mitogen withdrawal [28]. Overexpres-
sion of proneural proteins, such as Ascl1, in progenitors
of various origins results in their rapid neuronal differenti-
ation [19-22].
In the first instance, the role of Class I/II bHLH factors
in mediating neurogenesis was assessed in vitro. The effi-
ciency of neuronal differentiation following overexpres-
sion of Ascl1 alone or in combination with E-proteins
when NS5 cells were grown in proliferative culture con-
ditions was determined. Overexpression of Ascl1 induceda >3-fold increase in neuronal differentiation compared to
an empty control plasmid, as revealed by elevated Map2
or CD24 transcript expression, both of which are imma-
ture neuron markers (Figure 1A). Cotransfection of Ascl1
with either E-protein, i.e., E2-2, E47 (E2A isoform),
and HEB, further potentiated Ascl1-induced neuronal
differentiation by approximately 50 to 80% when Map2
expression was measured, and to a lesser extent when
CD24 transcription was probed (Figure 1A). In contrast,
measurement of ABCG2, a transcript expressed in NSCs,
showed opposite trends (Figure 1A). Together, these re-
sults illustrate the interchangeability of E-proteins in this
cellular context and their potential to promote Ascl1-in-
duced NS5 cell differentiation.
We next disrupted Class I/II bHLH transcriptional
activity in vitro and in vivo to investigate its effect on
NSC differentiation. We used a mutated form of the
E2A isoform E47, which lacks its nuclear localization
sequence and fails to translocate to the cell nucleus,
and therefore sequesters its binding partners within the
cytoplasm [29,30] (Figure 1B,D (insert)). While overex-
pression of dominant-negative E47 (dnE47) alone did
not influence Map2 transcript expression in proliferative
culture conditions (Additional file 1A), it efficiently pre-
vented Ascl1-induced neuronal differentiation of NS5 cells
as shown by the partial blockade of Map2 induction
(Figure 1C). We next tested the effect of dnE47 in SVZ
NSCs (i.e., radial glia cells (RGCs) at this early postnatal
stage) by performing postnatal in vivo electroporation.
Early after birth, NSCs can be easily distinguished from
their progeny based on morphological criteria, i.e., an
elongated cell body and the presence of a basal and apical
process [31,32]. Quantification revealed a dramatic block-
ade of differentiation following dnE47 overexpression,
with most electroporated RFP+ cells still presenting a clear
RGC morphology (Figure 1D,E). Interestingly, cells that
were already undergoing differentiation into non-radial
glial cells (non-RGCs) exhibited an enhanced proliferative
phenotype, as demonstrated by the doubling of the
number of Ki67+/RFP+ non-RGCs (Figure 1F, Additional
file 1B).
To confirm the accuracy in monitoring RGC differen-
tiation progression by electroporation and analysis of
morphological criteria, we next performed an in depth
antigenic characterization of RGCs and non-RGCs. At 2
days post-electroporation (2 dpe), RGCs were highly
positive for type-B cell markers (i.e., Vimentin and
Hes5-EGFP) and completely devoid of the type-C cell
marker Ascl1 (Figure 2A,B). In contrast, non-RGCs
were characterized as a mix of type-C (Ascl1+, 50%) and
type-A (Dcx+, 50%) progenitors (Figure 2A,B). Approxi-
mately half of the non-RGCs were proliferating, as indi-
cated by expression of Ki67 (Figure 2B). Those proliferating
cells were mostly Ascl1+ type-C cells (~60%, Figure 2C,
Figure 1 In vitro and in vivo modulation of bHLH function regulates neurogenesis. (A) Ascl1 nucleofection in NS5 cells caused an increased
Map2 and CD24 expression whilst conversely decreasing ABCG2 mRNA expression, as detected via RT-qPCR (100 ± 19.1 vs. 299.4 ± 8.4, 100 ± 19.6
vs. 392.1 ± 46.1, 100 ± 15.2 vs. 43.8 ± 2.5, respectively). Additionally, all E-proteins (E2-2, E47, HEB) further potentiated Ascl1-induced alteration in
marker expression, when co-nucleofected with Ascl1 (Map2: 299.4 ± 8.4 vs. 349 ± 21.2, 345.7 ± 10, 378.3 ± 21; CD24: 392.1 ± 46.1 vs. 423.3 ± 39.7,
508.5 ± 40.2, 426.4 ± 11.7; ABCG2: 43.8 ± 2.5 vs. 35.7 ± 2.9, 29.7 ± 0.5, 38.8 ± 0.6, respectively). (B) Schematic illustration of the dominant-negative
construct of E47 (dnE47), where the nuclear localization sequence is missing, therefore preventing its nuclear translocation and transcriptional
activity of its dimerizing partners (F, insert). (C) Co-nucleofection of dnE47 reduced Ascl1-induced neurogenesis as revealed by Map2 RT-qPCR
measurements (100 ± 4.2 vs. 66.8 ± 8.5). (D, E) Targeted in vivo electroporation of the dnE47-RFP construct rapidly reduced RGC differentiation, as
revealed by the lower proportion of non-RGCs, when compared to an empty RFP control plasmid (100 ± 5.5 vs. 12.6 ± 2.7) 2 days post-electroporation.
(F) Cycling progenitors (non-RGC) were maintained proliferating (Ki67+) following dnE47 induction (100 ± 9.6 vs. 182 ± 9.6). P values: *P <0.05;
**P <0.01; ***P <0.001. All quantifications were normalized to control conditions. Scale bars: D, 20 μm.
Fischer et al. Neural Development 2014, 9:23 Page 3 of 14
http://www.neuraldevelopment.com/content/9/1/23Additional file 1C), while only ~25% expressed the
type-A cell marker Dcx (Figure 2C, Additional file 1D).
Interestingly, ~10% of proliferating non-RGCs exhibited a
transitory phenotype between type-C and type-A cell
stages and were positive for both markers (Ascl1+Dcx+;
Figure 2C).
We next confirmed the blockade of RGC differenti-
ation after ectopic dnE47 using these antigenic criteria.
Overexpression of dnE47 resulted in an increase in the
number of Vimentin+/RFP+ cells (Figure 2D, Additional
file 1E), whilst the numbers of Ascl1+/RFP+ (type-C)
and Dcx+/RFP+ (type-A) precursors were concomitantly
decreased at 2 dpe compared to controls (Figure 2E,F,
Additional file 1F,G). Strikingly, the retention of a more
immature phenotype by the electroporated cells wasfurther supported by the 3-fold increase of Dcx+ cells,
still expressing type-C cell specific Ascl1 (Figure 2G).
Altogether, these experiments demonstrate that the
progression of RGC differentiation can be analyzed based
on morphological criteria and reveal a dependence of NSC
differentiation on Class I/II bHLH transcriptional activity
in the postnatal SVZ.
E-proteins exhibit a complex spatio-temporal pattern of
expression in the postnatal forebrain
Based on these findings, we further explored both spatial
and temporal E-protein expression in the postnatal and
adult forebrain. We first analyzed the spatial pattern of
expression by in situ hybridization (ISH) at postnatal day
6 (P6) and 60 (P60). All three genes coding for E-proteins
Figure 2 Antigenic properties of radial glial as well as non-radial glial cells and confirmation of differentiation blockade by dnE47
overexpression. (A, B), At 2 days post electroporation (dpe), 40% of the labeled cells showed morphological criteria of radial glial cells (RGCs, i.e.,
bipolar processes, apical connection to lateral ventricle (LV) lumen), while 60% presenting a spherical morphology were distant from the LV and
were defined as non-RGCs. Morphologically-defined RGCs express the NSC marker Vimentin (88.4 ± 0.7) and were EGFP positive in Hes5-EGFP
reporter mice (94.2 ± 2.4), but negative in Ascl1-EGFP reporter mice, in which type-B or type-C cells are labelled, respectively [33,34]. In contrast,
non-RGCs consisted of a heterogeneous population of type-C (i.e., Ascl1+, 53.6 ± 4.3) and type-A cells (i.e., Dcx+, 45.9 ± 0.2). Non-RGCs were frequently
proliferative (i.e., Ki67+, 58.2 ± 5.7). (C) A subsequent characterization of cycling non-RGCs revealed that most Ki67+ cells were type-C cells
(Ascl1+, 60.1 ± 4.4), whereas fewer were type-A cells (Dcx+, 22.9 ± 4.0). Notably, a minor population of cycling cells were double-positive for Ascl1
and Dcx (10.1 ± 1.4), probably representing a transition phase in between type-C and type-A phenotypes. (D–G) Antigenic assessment of RGC
differentiation blockade following dnE47 overexpression. Electroporation of dnE47 in the postnatal SVZ reduced RGC differentiation, as revealed
by the increased number of Vimentin+/RFP+ RGCs (D) and concomitant decrease of Ascl1+/RFP+ (E) and Dcx+/RFP+ (F) non-RGCs, respectively,
when compared to an empty RFP control plasmid 2 dpe (Vimentin: 100 ± 3.2 vs. 150.5 ± 1.6; Ascl1: 100 ± 8.4 vs. 48.2 ± 3.1; Dcx: 100 ± 3.3 vs.
39.5 ± 6.3). This blockade of differentiation was further supported by an increase in Dcx+/RFP+ type-A cells retaining expression of the type-C
cell marker Ascl1 (Dcx+Ascl1+, 100 ± 25.7 vs. 308.5 ± 50.3) (G). P values: *P <0.05; **P <0.01; ***P <0.001. Quantifications were normalized to
control conditions (D–G). Scale bars: A, 10 μm.
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http://www.neuraldevelopment.com/content/9/1/23(E2-2, E2A, and HEB) were abundant in the postnatal
forebrain and were enriched in germinal zones, i.e.,
dentate gyrus, SVZ, and RMS at P6 (Figure 3A,B).
These results were confirmed by real-time quantitative
polymerase chain reaction (RT-qPCR) measurement
from the microdissected lateral SVZ and adjacent par-
enchyma (i.e., striatum). All E-protein transcripts were
enriched in the SVZ, with a clear predominance of E2-
2 and E2A (Figure 3C). At P60, E-protein transcripts
were generally less abundant compared to earlier post-
natal ages. While E2-2 expression was still enhanced in
the SVZ and the RMS, E2A and HEB expression levels
were only marginally higher than in non-germinal regions
(Figure 3A,B), thus implying that E2-2 may be requiredFigure 3 E-protein mRNA expression is enriched in germinal regions
differentiation in vitro and in vivo. (A) ISH of E2-2, E2A, and HEB revealed
and the dentate gyrus, when compared to non-neurogenic regions (i.e., thala
A. (C) E2-2, E2A, and HEB transcripts were highly expressed in the lateral SVZ c
vs. 0.5 ± 0.06, 0.02 ± 0.004 vs. 0.46 ± 0.08, 0.003 ± 0.0004 vs. 0.07 ± 0.01, respect
in NS5 cells (two-way ANOVA followed by Dunnett’s post hoc test). Differe
transcripts, an early neuronal marker, and normalized to GAPDH and show
was enhanced in more mature PSA-NCAM+ MAC sorted neuroblasts comp
vs. 687.8 ± 226.4, 100 ± 9.9 vs. 145.4 ± 15.4, 100 ± 12.1 vs. 144.0 ± 17.4, resp
(100 ± 34.0 vs. 1291.3 ± 438.6) and CD24 (100 ± 17.8 vs. 270.1 ± 48.1) transcript
22.1 ± 4.5) and Id1 (100 ± 6.5 vs. 72.8 ± 4.7) were enriched within Prominin-1+
were normalized to control conditions (D, E).for neuronal differentiation continually during development
and into adulthood.
Having demonstrated an enrichment of E-protein
transcripts in germinal regions of the postnatal fore-
brain, regulation during early neuronal differentiation
was assessed. In vitro differentiation of the NS5 cell line
increased the expression of all E-protein transcripts. Up-
regulation of E2-2 and HEB had occurred following 24 h,
before any increase of doublecortin (Dcx), a neuronal
differentiation marker, could be detected. After 48 h of
differentiation, all E-protein transcripts were significantly
upregulated (Figure 3D).
A similar upregulation was observed in vivo. Early pro-
genitors and committed neuroblasts were isolated basedof the postnatal and adult forebrain and is increased during NSC
its enhanced expression in the SVZ (dashed zone at P60), the RMS,
mus, cortex) at P6 as well as P60. (B) Inverted greyscale quantification of
ompared to the striatum (dashed zone circling both regions) (0.18 ± 0.03
ively). (D) Upon differentiation, E-protein mRNA levels were upregulated
ntiation progress was confirmed by upregulation of doublecortin (Dcx)
n as a percentage vs. D0. (E) E-protein transcription, in particular E2-2,
ared to earlier Prominin-1+ (or CD133+) NSCs/progenitors (100 ± 32.0
ectively). Cell sorting efficiency was confirmed by enrichment of Dcx
s in neuroblasts, while the generic NSC transcripts GFAP (100 ± 20.4 vs.
sorted cells. P values: *P <0.05; **P <0.01; ***P <0.001. All quantifications
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Prominin-1 and PSA-NCAM, respectively. Measurements
of cell-specific markers confirmed the efficiency of the
approach by showing that Prominin-1+ sorted cells were
enriched for the stem cell markers GFAP and Id1, while
Dcx and CD24 enrichment was prominent in PSA-NCAM+
sorted cells. Measurements of E-protein transcripts by
RT-qPCR revealed that E2-2 and, to a lesser extent, E2A
and HEB, were strongly upregulated in the postnatal SVZ
during NSCs differentiation (Figure 3E).
Altogether, our results indicate that E-protein expres-
sion is spatially and temporally regulated in a pattern that
matches NSC differentiation during postnatal forebrain
development.
E-protein manipulation alters the progression of NSC
differentiation in the postnatal SVZ
We next performed further E-protein gain-of-function
(GoF) and loss-of-function (LoF) experiments in the
postnatal lateral SVZ, by means of plasmid electropor-
ation (as above) (Figure 4A). We focused this functional
characterization onto E2-2, which appears to be the most
prominent E-protein expressed in the postnatal and adult
SVZ (see above), and E2A, which is the best studied E-
protein in CNS development [23,25,29,35-37].
GoF experiments resulted in the rapid transformation
of RGCs into non-RGCs. Thus, whilst E2-2 and E2A
overexpression increased the transformation of RGCs
into non-RGCs by 30% and 40%, respectively, both E2-2
and E2A silencing decreased it by 20% (Figure 4B,C,
Additional file 1H). We next focused our analysis on
non-RGCs, which, at this early timepoint (2 dpe), consisted
of transient amplifying progenitors (type-C) and neuro-
blasts (type-A) (Figure 2A,B). E-protein overexpression
significantly reduced the proliferation of non-RGCs, as
demonstrated by a ~45% decrease in the number of green
fluorescence protein positive (GFP+) non-RGCs express-
ing the cell cycle marker Ki67. In contrast, LoF enhanced
the proliferation capacity of non-RGCs (Figure 4D). Inter-
estingly, these effects were more pronounced following
E2-2 silencing, consistent with its higher expression in the
postnatal SVZ compared to E2A (see above).
Altogether, these data are in agreement with the results
obtained with the dnE47 construct (Figure 1D–F) and
suggest that E-proteins control the differentiation of
NSCs, and influence the cycling behavior of their progeny.
We next tested whether the changes in proliferation
observed following E-protein GoF could be explained by
cell cycle exit induction. Dividing cells in S-phase that
incorporated 5-ethynyl-2′-deoxyuridine (EdU) 24 h prior
to sacrifice, but did not re-enter another round of cell
division (i.e., cell cycle exit), would no longer express
Ki67. We quantified the number of EdU+Ki67–/EdU+
cells and found a doubling in the number of progenitorsthat had exited the cell cycle, when E2-2 was overex-
pressed (Figure 5A), whereas a smaller number of pro-
genitors exited the cell cycle upon E2-2 silencing
(Figure 5B). Finally, we tested whether E2-2-induced cell
cycle exit resulted in an abortive differentiation or whether
cells appropriately completed their differentiation into
Dcx+ neuroblasts. We observed a ~30% increase of Dcx+
neuroblasts (type-A) within the postnatal forebrain at 2
dpe (Figure 5C, Additional file 1I), which paralleled the re-
duction of the number of RGCs described above, whereas
the number of Ascl1+ type-C cells remained unaltered
(Figure 5D, Additional file 1J).
Taken together, these results highlight an important
role of E-proteins in controlling the timing and progression
of NSC differentiation in the postnatal SVZ. Thus,
upon E2-2 overexpression, a concomitant decrease of
type-B RGCs and increase of Dcx+ type-A cells was ob-
served. These observations, together with the stable
number of Ascl1+ type-C cells, suggest a more rapid
differentiation of E2-2 overexpressing cells as schematized
in Figure 5E,F.
E47 disruption is not sufficient to mediate the switch of
Ascl1-dependent transcription
E-proteins induce NSC differentiation by transactivation
of bHLH proneural proteins. Among those is Ascl1,
expressed mainly by progenitor cells in the postnatal
forebrain [19,38]. We confirmed the interdependence
of E-proteins and Ascl1 by NSC differentiation induction,
combining GoF and LoF experiments in isolated progeni-
tors in vitro. Ascl1 knock-down resulted in a complete loss
ofMap2 mRNA transcription, when E2-2 or E47 were con-
comitantly overexpressed. This confirms that E-protein ac-
tivity is largely dependent on Ascl1 expression. On the
other hand, Ascl1 is still able to exert its function although
to a lesser extent upon silencing of E2-2, but not after
silencing E2A, illustrating both redundancy but also a
strong dependency on E2A expression in SVZ-derived
progenitor cells (Figure 6A).
The bHLH protein Ascl1 has recently been shown to
control proliferation and differentiation in neural pro-
genitors by sequentially activating cell cycle progres-
sion and cell cycle arrest genes in a context-dependent
manner [22]. Therefore, we next assessed whether
modifications in E-protein expression levels that occur
during neural progenitor cell differentiation could me-
diate this molecular switch. E2A, in the form of E47,
known to be the main E-protein binding to Ascl1 [21],
was overexpressed or silenced in isolated neurosphere
cultures and the level of expression of Ascl1 targets,
reported to be differentially expressed during cell cycle
progression (FoxM1, Cdk4) and cell cycle arrest (Gadd45g,
Ccng2, Btg2, Prmt2) [22], was measured by RT-qPCR. No
consistent change in expression of genes differentially
Figure 4 E2-2 and E2A sequentially affect RGC differentiation and progenitor proliferation. (A) Representative illustration of a green
fluorescence protein (GFP) plasmid electroporation into the lateral wall of the LV. (B) In vitro characterization of the shRNAs used in this study.
shRNA against E2-2 or E2A decreased E2-2 or E2A expression (100 ± 18.9 vs. 17.2 ± 2.4 or 100 ± 20.2 vs. 20.9 ± 2.5, respectively) within neurosphere
cultures, when co-nucleofected with E2-2 or E47 overexpression plasmids, respectively. (C) E2-2 and E47 overexpression constructs increased
transition from RGCs (bipolar processes, apical connection to LV lumen) to non-RGCs (no processes, spherical morphologies, distant from the LV
wall) at 2 dpe (100 ± 3.9 vs. 130.5 ± 3.0 or 139.7 ± 1.4, respectively). When shRNA plasmids against E2-2 or E2A were applied, most electroporated
cells maintained a RGC morphology, as reflected by the reduced ratio of non-RGC cells compared to control conditions (100 ± 3 vs. 81 ± 6.4 or
82.9 ± 3.6, respectively). Confocal micrographs illustrate RGCs and non-RGCs coexisting in the neurogenic niche. Inserts show a schematic view of
the RGC to non-RGC transition. (D) E2-2 and E47 overexpression constructs decreased Ki67 immunoreactivity within progenitors (non-RGC) at 2
dpe (100 ± 5.6 vs. 61 ± 3.5 or 64.7 ± 4.1, respectively). shRNA constructs against E2-2 and E2A-induced opposite effects (100 ± 8 vs. 216 ± 13.2 or
161.9 ± 12.7, respectively). Confocal micrographs illustrate representative non-RGCs positive or negative for Ki67, respectively. P values: *P <0.05;
**P <0.01; ***P <0.001. All quantifications were normalized to control conditions. Scale bars: C, 20 μm; D, 10 μm.
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LoF (Figure 6B).
In summary, the divergent context-dependent function
of Ascl1 in promoting cell proliferation and in triggering
differentiation, as described recently [22], is apparently
independent of E-protein activity. Rather, these findings
propose that E-protein upregulation during NSC differ-
entiation is likely to act in parallel with other signaling
pathways to fine-tune differentiation progression in an
Ascl1-dependent manner [39].Discussion
In the present study, we demonstrate enriched expression
of E-proteins in postnatal germinal regions of the murine
forebrain and highlight their key role as transcriptional or-
chestrators of postnatal SVZ neurogenesis.
bHLH family members are known to regulate a variety
of developmental programs in several tissues of the organ-
ism, such as myogenesis, hematopoiesis, and pancreatic
and heart development, as well as neurogenesis [5]. In the
CNS, proneural Class II proteins are the most studied
Figure 5 E2-2 alteration influences cell cycle exit of progenitors in vivo. (A) E2-2 overexpression increased cell cycle exit (EdU+Ki67–/EdU+)
among the progenitor cell population (non-RGC) compared to control conditions at 2 dpe (100 ± 7.5 vs. 184.9 ± 18.0). Confocal micrographs show
representative non-RGCs (GFP+) having cycled within 24 h prior to sacrifice (EdU+) and having re-engaged (Ki67+) or exited the cell cycle (Ki67–),
respectively. (B) In contrast, knock-down of E2-2 decreased cell cycle exit within the progenitor pool as illustrated by the increased Ki67 immunoreactivity
among EdU+ non-RGCs, when compared to control conditions (Scrambled) (100 ± 7.8 vs. 65.8 ± 1.3). (C, D) E2-2 overexpression also increased the number
of Dcx+ neuroblasts (100 ± 0.5 vs. 128.1 ± 2.9) (C), whereas the number of Ascl1+ type-C cells remained unchanged (100 ± 6.4 vs. 94.6 ± 9.2) (D). (E)
Percentage of cell type composition (i.e., type-B = RGC, type-C = Ascl1+, type-A = Dcx+) upon E2-2 overexpression, when compared to an empty
control plasmid at 2 dpe (30.7 ± 4.6 vs. 14.2 ± 2.3, 30.0 ± 1.2 vs. 35.6 ± 2.5, 39.2 ± 0.3 vs. 50.2 ± 1.8, respectively). (F) Summary model: E2-2
orchestrates neurogenesis progression within the murine forebrain. P values: *P <0.05; **P <0.01; ***P <0.001. Quantifications were normalized
to control conditions (A–D). Scale bars: A & B, 20 μm.
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indispensable and sufficient to induce neurogenesis in
drosophila [40], C. elegans [41,42], and mice [43]. During
telencephalic development, Neurog2 and Ascl1 confer an
opposing dorso-ventral expression gradient to specify dis-
tinct neuronal populations [44].
However, less is known regarding Class I bHLH protein
expression patterns and their role during neurogenesis. In
drosophila, Daughterless (E-protein homolog) knock-out
results in defective precursor differentiation [45,46]. In
contrast, deletion of single Class I bHLH protein members
in rodents led to no gross anatomical phenotype [26] or
spatially restricted developmental deficits [47]. Deletion
of multiple E-proteins resulted in stronger phenotypes
highlighting some degree of redundancy in betweenthese genes [26]. Our co-expression experiments confirmed
the potential interchangeability of E-proteins, since E2-2,
E47, and HEB were equally potent in transactivating Ascl1,
even though the LoF analysis revealed Ascl1 to prefer-
entially bind E47. Sequence analysis studies revealed ex-
tremely high sequence conservation within, as well as
beyond, the HLH domains supporting possible redundancy
among individual E-proteins [23]. Indeed, functional re-
placement of the mouse E2A gene with an E2A promoter-
driven human HEB cDNA rescued B-cell commitment
and differentiation during B-lymphopoiesis [37].
Furthermore, expression studies have proposed a regula-
tion of E-protein transcription during development, with a
gradual restriction to germinal regions in the CNS [25],
supporting key neurogenesis functions. Our ISH combined
Figure 6 E47 fails to trigger Ascl1 to switch from proliferation
to differentiation target genes. (A) Map2 mRNA expression was
elevated when Ascl1 was overexpressed in isolated neurospheres
in vitro (100 ± 19.1 vs. 299.4 ± 5.8). Concomitant knock-down of E2-2
or E2A using shRNA, respectively, reduced or abolished Ascl1-dependent
Map2 expression (299.4 ± 5.8 vs. 222.2 ± 3.7 or 94.9 ± 9.8, respectively).
More strikingly, Ascl1 silencing decreased Map2 expression level
to control conditions, when E2-2 (100 ± 19.1 vs. 242.4 ± 34.2,
242.4 ± 34.2 vs. 100.3 ± 4.9) or E47 (100 ± 19.1 vs. 214.6 ± 7.1, 214.6 ± 7.1
vs. 125.7 ± 13.6) was overexpressed. (B) Although significant expression
changes could be detected, E-protein gain-of-function did not
systematically promote activation of Ascl1 target genes mediating
cell cycle arrest. Inversely, E-protein silencing did not activate Ascl1
target genes mediating cell cycle progression. P values: *P <0.05;
**P <0.01; ***P <0.001. All quantifications were normalized to
control conditions.
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enrichment of all E-protein transcripts in postnatal and
adult germinal regions of the forebrain when compared
to non-neurogenic regions. Notably, these expression
experiments uncovered E2-2 as the most abundant
E-protein in the SVZ, followed by a less prominent
expression for E2A and HEB. Additionally, E-proteins
seem not only to be restricted spatially but also temporally
during lineage progression. More differentiated progeni-
tors exhibited increased transcription levels in vitro as well
as in vivo, further implicating a specialized function in
maintaining proper neurogenesis behavior. Altogether,
these results highlight a complex regulation of E-protein
expression in germinal regions of the postnatal forebrain.
The dramatic blockade of NSC differentiation and
subsequent neurogenesis observed following dnE47 over-
expression in vitro as well as in vivo underlines the im-
portance of a functional bHLH network for lineage
progression. Based on these findings, we further aimed
at manipulating E-protein expression more concisely
in the lateral SVZ using overexpression and shRNA
plasmids within an established postnatal electroporation
approach [31,32]. Major alterations in progenitor prolifer-
ation and cell cycle exit were evident. These results are in
agreement with a previously described role of E2A in cell
cycle regulation in transiently transfected NIH3T3 fibro-
blasts, by activating cyclin-dependent kinase inhibitors
[27,48,49]. Moreover, Id proteins, known E-protein antag-
onists (see above), enhance cell cycle duration and prevent
cell cycle exit, which was further confirmed with a de-
creased cyclinD1 and increased p27Kip1 (cyclin-dependent
kinase inhibitor 1B) expression within the VZ of triple
knock-out mice [18]. In line with Id protein mediated an-
chorage to the neurogenic niche [18], E-proteins were also
reported to actively repress expression of E-cadherin, a
cell adhesion molecule [50,51]. Recent studies in dros-
ophila, revealing a direct transcriptional regulation of
Emc (Id protein homolog) by Daughterless, coupled
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V bHLH members [6], results in an autoregulatory
feedback [24,52]. In addition, E-protein expression and
therefore lineage progression seems to be initially mediated
by extracellular signaling pathways, which is consistent with
earlier reports, suggesting a general role for Shh and BMPs
in SVZ neurogenesis [53-55]. In drosophila, it was demon-
strated that Hh (Shh homolog) and Dpp (BMP homolog)
specifically repress Id expression and thus increase E-
protein activity [24], ultimately leading to germinal niche
detachment and altered cell cycle behavior.
Our findings suggest that the effects of E-proteins on
SVZ NSC differentiation are entirely dependent on Ascl1,
which is expressed in all postnatal SVZ progenitors
[19,56]. Knock-down of Ascl1 entirely abrogated the
proneural activity of E2-2 and E2A, demonstrating that
E-proteins converge with the same Class II bHLH protein.
The incomplete loss of Ascl1 activity when E2-2 is silenced
is likely due to a persistent endogenous E47 activity, as
Ascl1 seems to rely more on E2A than on E2-2, demon-
strated by the absence of Ascl1 activity upon E2A silencing.
Recent findings propose that sustained Ascl1 expression
favors cell differentiation, whereas oscillatory expression
correlates more with proliferative cell fates [57]. Given
that E-proteins, in competition with Id proteins, tightly
regulate Ascl1 protein stability [58] and that Ascl1 has
lately been demonstrated to target two subsets of genes,
namely proliferation- and differentiation-associated genes
[22], we investigated a role for E-proteins in mediating this
switch in binding bias. However, in the present study, E2A
alterations did not induce directed and systematic gene
expression changes, at least for the Ascl1 target genes
tested, most likely mitigating the probability of E-proteins
to induce differentiation through promoting Ascl1 binding
and activation of cell cycle arrest genes. This implies that
E-proteins are likely to operate in parallel with other sig-
naling pathways to fine tune differentiation progression in
an Ascl1-dependent manner [39].
Although our results did not reveal significant differ-
ences in the expression pattern of distinct E-proteins
during postnatal SVZ neurogenesis, and suggest an
interchangeability of E-proteins in the context of Ascl1-
induced SVZ NSC differentiation, it should be noted that
the dimerization properties of bHLH proteins can be af-
fected at the post-translational level. For example, GSK3β
phosphorylation of Neurog2 was described to influence its
dimerization with E47 in the developing cortex, thereby
affecting its transcriptional activity [59]. Similar mecha-
nisms might be at play in the postnatal SVZ to fine tune
the choice of proneural/E-protein-binding partners and
regulate individual aspects of NSC differentiation, such as,
for example, specification. Previous studies have indeed
demonstrated a specific role of E2-2 for the generation
of a unique subset of neural progenitors during pontinedevelopment [47], despite the presence of other E-proteins.
Also, B- and T-lymphocyte specification was shown to be
orchestrated by E2A and HEB [60,61]. Whether Class I/II
bHLH protein dimerization is dynamically regulated in the
postnatal SVZ to influence fate specification is currently
unknown and will be the subject of future investigations.
Performing such experiments in the postnatal SVZ is par-
ticularly attracting due to the regional expression of some
proneural proteins as, for example, Neurog2, which shows
dorsal enrichment in the postnatal SVZ in a population that
gives rise to glutamatergic neurons [62,63].
Conclusions
In the present work, we demonstrate a diverse expression
pattern of Class I bHLH proteins and underpin their
underestimated significance in orchestrating early neur-
onal lineage progression. However, the precise mechanism
behind E-proteins regulating NSC differentiation remains
to be elucidated, but is unlikely to rely solely on Ascl1
heterodimerization.
Methods
Cell culture and in vitro nucleofection
The mouse embryo-derived and immortalized RGC line
NS5 was cultured as described earlier [28] and was
nucleofected following the manufacturer’s instructions
using a 4D-nucleofector device with SG solution (Lonza,
Basel, Switzerland) and the EN150 program with a max-
imum of 0.5 μg of plasmid DNA per 1 × 106 cells. NS5
cell differentiation was achieved by plating cells into
polyornithin-coated (0.001% in H2O, Sigma-Aldrich, St.
Louis, MO, USA) and laminin-coated (20 μg/mL in H2O,
Life Technologies, Carlsbad, CA, USA) flasks in D1
medium (Euromed-N stem cell medium; Lucerna Chem,
Lucerne, Switzerland) supplemented with 1% penicillin/
streptomycin, 0.25% L-glutamine, 1% B27 (Life Technolo-
gies), 0.5% N2 (Life Technologies), and 5 ng/mL FGF2
(Peprotech, Hamburg, Germany) [64].
Neurosphere-forming progenitor cells were isolated
from the SVZ of P4 aged animals. The SVZ was micro-
dissected and the tissue digested with a solution of
DNAse I (Worthington, Lakewood, NJ, USA), Papain
(Worthington), and Dispase II (Roche, Basel, Switzerland),
subsequently triturated and filtered through a 70 μm cell
strainer (BD Biosciences, Franklin Lakes, NJ, USA). Cells
were plated into DMEM/F12 medium supplemented with
1% N2, EGF, FGF2 (both 20 ng/mL, Peprotech), heparin
(1 μg/mL), and 1% penicillin/streptomycin. For nucleofec-
tions, a mouse neural stem cell solution (Lonza), program
DS113, and a maximum of 1 μg of plasmid DNA per
1 × 106 cells were used.
Both NS5 and progenitor cells were subjected to
RNA isolation and subsequent RT-qPCR 24 to 48 h
post-nucleofection.
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All animal experiments were performed in agreement
with the Canton of Zurich veterinary office guidelines
(authorization 182/2011). All mice used in this study
were of the CD1 (Swiss mice) strain and were obtained
from the Charles River laboratory.
Electroporation of RGCs lining the lateral ventricle
was performed on postnatal-day-2 mice (P2), as described
previously [31,32]. In brief, following anesthesia by
hypothermia, P2 pups were injected with 2 μL of plasmid
solution (5 μg/μL in PBS). Fast Green 1% (Sigma-Aldrich)
was used to assess accuracy of the intra-ventricular injec-
tions. Successfully injected mice were subjected to five
electrical pulses (95 V, 50 ms, separated by 950 ms inter-
vals) using the ECM 830 BTX electroporator (Harvard
Apparatus, Holliston, MA, USA) and tweezer electrodes
(5 mm diameter; BTX Tweezertrodes, Harvard Apparatus)
coated with conductive gel (Signa gel, Parker Laboratories,
Fairfield, NJ, USA). For proliferation studies, 50 mg/kg
5-ethynyl-2′-deoxyuridine (EdU) were administered sub-
cutaneously 24 h prior to sacrifice.
Tissue processing
Two days post-electroporation, mice were deeply anesthe-
tized (150 mg/kg pentobarbital, i.p.) and transcardially
perfused with Ringer solution supplemented with heparin
(250 mg/L, Sigma-Aldrich) followed by 4% paraformalde-
hyde (PFA) (Sigma-Aldrich). Then, 50 μm thick vibratome
sections (Leica, Wetzlar, Germany) were collected as a
series of six encompassing the entire rostro-caudal extent
of the lateral ventricle. Sections were stored at –20°C in
antifreeze solution (25% Glycerol, 25% Ethylenglycol and
50% 0.1 M PB).
Immunostaining
All immunostainings were performed on a complete series
of free-floating sections. Blocking and permeabilization
were achieved by incubating the sections for 2 h in 0.1 M
PB supplemented with 0.4% Triton-X100 and a TNB buf-
fer (thereafter mentioned as 0.4% TNB-TX100) consisting
of 0.05% Casein (Sigma-Aldrich), 0.25% bovine serum
albumin (Sigma-Aldrich), and 0.25% Topblock (Lubio
Science, Lucerne, Switzerland) at room temperature.
Afterwards, primary antibody incubations were performed
in 0.4% TNB-TX100 at 4°C overnight (M α Ki67, 1:300 (BD
Biosciences); Rb α Ki67, 1:500 (MM France, Francheville,
France); G α Dcx, 1:300 (Santa Cruz Biotechnology, Santa
Cruz, CA, USA); Ch α Vimentin, 1:1000 (Millipore,
Darmstadt, Germany); and M α Ascl1, 1:300 (BD Bio-
sciences)). Then, incubation with species-matched second-
ary antibodies (Life Technologies) was performed for 2 h at
4°C in 0.4% TNB-TX100. GFP signal was amplified using a
biotin-conjugated secondary antibody against the GFP
primary antibody (Ch α GFP, 1:1,000 (Aves Labs, Tigard,OR, USA)). In addition, the tissues were incubated for
15 min with a biotin-specific streptavidin Alexa 488 complex.
Finally, sections were counterstained using 4′,6-diamidino-2-
phenylindole (DAPI, Sigma-Aldrich) and coverslipped with
antifading mounting medium (Vectashield, Vector
Labs, Burlingame, CA, USA).
For nuclear stainings, an antigen retrieval protocol was
applied. Sections were incubated with 10 mM tri-sodium
citrate buffer (+0.05% Tween 20, pH 6.0) for 30 min at
80°C and 20 min at room temperature.
Detection of EdU incorporation was performed using
the Click-it EdU system (Life Technologies) according to
the manufacturer’s instructions.In situ hybridization
In situ RNA hybridization was performed as previously
described [65]. After dissection, postnatal or adult brains
were fixed in 4% PFA at 4°C for 48 or 24 h, respectively,
cryoprotected in 30% sucrose at 4°C overnight, cryo-
sectioned at 20 μm on consecutive slides, and stored at
−80°C. Sections were acetylated with 0.1 M triethanola-
mine and 2.5 μL/mL acetanhydride for 10 min and
additionally fixed in 4% PFA at RT for 15 min before
prehybridization for 4 h followed by 1 to 2 μg/mL probe
hybridization for 16 h at 65°C. The antisense E2-2
[NM_013685], E2A [NM_011548], and HEB [NM_011544]
probes were derived from plasmid constructs, whereas
linearized templates were transcribed using a T7 RNA
polymerase (Thermo Fisher Scientific, Waltham, MA).
Anti-DIG FAB (1:2000 (Roche)) immunostaining was
applied at 4°C overnight and subsequently developed in
buffer containing BCIP (175 μg/mL) and NBT (100 μg/mL)
for 12-48 h.Microdissection and MAC sorting
To determine the spatio-temporal E-protein expres-
sion pattern, the SVZ or the striatum were micro-
dissected from mice aged P6 as described in previously
published protocols [66]. In brief, NSCs and neuro-
blasts were isolated by magnetic affinity cell sorting
(MACS) using conjugated antibodies against the trans-
membrane proteins Prominin-1, also known as CD133,
and PSA-NCAM. Dissected tissues were pooled in
Hanks buffered salt solution (Life Technologies) and
dissociated using a trypsin-based kit following manufac-
turer’s guidelines (Miltenyi Biotec, Bergisch Gladbach,
Germany). Then, anti-Prominin-1 or anti-PSA-NCAM
antibodies conjugated with magnetic beads (Miltenyi
Biotec) were applied to the cell suspension for 30 min
at 4°C before they were passed through MACS separ-
ator columns (Miltenyi Biotec). Sorted cells were snap-
frozen for subsequent RT-qPCR. One litter represents
1 ‘n’ number.
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RNA was extracted, processed, and amplified from tis-
sues/cells as previously described [32]. For RT-qPCR,
20 ng of cDNA were loaded with 5 μm of forward and




CTGA, rv_CCGGCTCTTCCCATTGG; HEB: fw_CCAT
CCCCAAATTCTGACGAT, rv_GCTGGCTCATCCCATT
















CA, rv_AGATACAGCCAACGCTCCAC), SYBR green
mastermix (Roche), and DNAse/RNAse free H20 (Sigma-
Aldrich) onto 96-well plates for LightCycler 480 (Roche).
All samples were run in duplicates or triplicates, whereas
glyceraldehyde-3-phosphate dehydrogenase (GAPDH:
fw_CGACTTCAACAGCAACTCCCACTCTTCC, rv_TG
GGTGGTCCAGGGTTTCTTACTCCTT) was used as
reference gene. Relative gene expression was determined
using the ΔΔ-CT method [67].
Analysis
Images were acquired with a laser scanning confocal
microscope (Olympus IX 81, Olympus, Tokyo, Japan)
equipped with a 20× or 40× objective, or with an epi-
fluorescence microscope (Leica DM5500 B, Leica). Quanti-
fications following in vivo electroporations are based on an
average cell count of 254 successfully transfected cells per
animal (n ≥5). Each animal represented 1 ‘n’ number.
Morphological criteria to define RGCs were bipolar
morphology and apical connection to the LV lumen.
Morphological criteria to define non-RGCs were absence
of apical and basal processes (i.e., roundish appearance),
and absence of contact to the LV lumen [31,32].
All data are expressed as mean and standard error of
the mean (±SEM). P values were determined using
unpaired t-test or two-way ANOVA followed by Dunnett’s
post hoc test (GraphPad Prism v5 software, San Diego,
CA, USA).Additional file
Additional file 1: (A) In contrast to the blockade of Ascl1-induced
neuronal differentiation shown in Figure 1C, dnE47 overexpression alone
did not affect Map2 expression in NS5 cells kept in proliferative culture
conditions (100 ± 1.0 vs. 93.9 ± 5.3). (B) Ki67 immunoreactivity revealed
an increased non-RGC proliferation after dnE47, when compared to empty
control conditions, as shown in Figure 1E. (C & D) Antigenic characterization
of Ki67+ non-RGCs, demonstrated that both Ascl1+ type-C (C, Figure 2C)
and, to a lesser extent, Dcx+ type-A cells (D, Figure 2C) proliferate.
(E–G) Representative immunostainings for detected changes in
the expression of cell type specific markers; i.e., RGC = Vimentin+ (E),
type-C = Ascl1+ (F), type-A = Dcx+ (G), following dnE47 expression,
as quantified in Figure 2D–G. (H) Absence of cross-reactivity between
shRNAs against E2A and E2-2 transcripts (see also Figure 4B). E2A
mRNA expression was not reduced when shRNA against E2-2 was
applied in vitro (100 ± 7.6 vs. 111.5 ± 1.1). Similarly, E2-2 mRNA expression
was not reduced when shRNA against E2A was used (100 ± 2.7 vs. 148.6 ±
8.7). (I, J), Representative immunostainings for Dcx and Ascl1 illustrating an
increased Dcx expression (I, quantified in Figure 5C) and unaltered Ascl1
expression (J, quantified in Figure 5D), when E2-2 was overexpressed.
Arrows identify representative cells for each experimental condition.
Quantifications were normalized to control conditions. Scale bars: B–G, I, J, 20 μm.
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